Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

40.97
Delayed Data
As of May 25
 +0.76 / +1.89%
Today’s Change
37.63
Today|||52-Week Range
54.98
-3.94%
Year-to-Date
Novo Nordisk IDegLira Recommended by FDA Advisory Committee
May 25 / Zacks.com - Paid Partner Content
Better Buy: Alnylam Pharmaceuticals, Inc. vs. Ionis Pharmaceuticals Inc.
May 24 / MotleyFool.com - Paid Partner Content
European Markets End in Positive Territory; Rally for Second Day
May 25 / TheStreet.com - Paid Partner Content
Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move -- Here's Wh...
May 24 / MotleyFool.com - Paid Partner Content
Sanofi Moves to Oust Medivation Board
May 25 / TheStreet.com - Paid Partner Content
Sanofi Diabetes Drugs Briefing Documents Raise Concerns
May 24 / Zacks.com - Paid Partner Content
Lilly's (LLY) R&D Update, Targets 20 New Launches by 2023
May 25 / Zacks.com - Paid Partner Content
Novartis' Cardiovascular Drug Gets Positive Recommendation
May 23 / Zacks.com - Paid Partner Content
Exelixis' Kidney Cancer Drug Cabometyx Positive in Phase II
May 24 / Zacks.com - Paid Partner Content
Endonovo Therapeutics: Innovative Treatment, Catalyst Create Compelling Opportunity
May 23 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close40.21
Today’s open41.00
Day’s range40.91 - 41.17
Volume1,531,843
Average volume (3 months)2,027,783
Market cap$104.7B
Dividend yield3.98%
Data as of 4:02pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)-17.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.70%
Revenue growth (last year)-14.57%
P/E ratio24.5
Price/Sales2.96
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.41+0.96%
NVONovo Nordisk+1.33+2.42%
ABBVAbbVie+0.52+0.86%
AGNAllergan-1.04-0.45%
Data as of 4:02pm ET, 05/25/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)$0.73
Annual revenue (last year)$38.1B
Annual profit (last year)$4.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts

Partner Offers

Search for Jobs